Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05879822
Title	A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Incyte Corporation
Indications	hepatocellular carcinoma skin melanoma Advanced Solid Tumor transitional cell carcinoma clear cell renal cell carcinoma lung non-small cell carcinoma
Therapies	INCB099280
Age Groups:	adult \| senior
Covered Countries	TUR \| ROU \| NZL \| HUN \| GRC \| BRA